<p><b>A)</b> ROC curves showing sensitivity and specificity for individual biomarkers. <b>B)</b> Predicted risk values from two-step model based on hyaluronan and N-ERC/mesothelin. Cases with a predicted risk>0.9 were considered positive (above shaded area). <b>C)</b> ROC curve for the two-step model.</p
<p>Performance of the random forest classifier (red) compared to a commercial mesothelin assay (blue...
<p>ROC curves and AUCs for the clinical (solid blue), ECG (dashed red), and combined (dotted black) ...
<p>In (A) <i>AKY</i> and (B) <i>BBJ</i>, case samples with PSA 1–10 ng/ml and all the control sample...
<p><b>A)</b> and <b>B)</b> Levels of hyaluronan and N-ERC/mesothelin, respectively, in the validatio...
<p>Sensitivity and specificity was maximized at a sensitivity of 0.858 and specificity of 0.623.</p
<p>Fig 3a. ROC curves for different biomarkers and PSI. Fig 3b. ROC curves for the PSI & MR-proADM p...
<p>(a) shows genes contained in the integrated BRCA pathway, (c) shows genes contained in the GBM KE...
<p>Values along the indicated diagonal line (<i>line of no-discrimination</i>) reflect a random gues...
<p>ROC curves for cardiovascular morbidity and mortality of three models: traditional risk markers (...
<p>ROC curves for combined risk factors (RF) alone, TRAIL alone, and the model. TRAIL: AUC 0.59 (95%...
Model A (blue line) incorporates classical risk factors and five GWAS-identified SNPs, whereas model...
<p>In training set (A), at each immunohistochemical staining score of 38 tissue molecules and 3 sero...
<p>The sensitivity (y axis) was plotted versus 1−specificity (x axis) in case of each potential biom...
<p>ROC curves analyses to represent sensitivity/specificity of each biomarker, and the Area Under th...
<p>True positive rate is denoted TPR and false positive rate is denoted FPR in the Figure. A. Evalua...
<p>Performance of the random forest classifier (red) compared to a commercial mesothelin assay (blue...
<p>ROC curves and AUCs for the clinical (solid blue), ECG (dashed red), and combined (dotted black) ...
<p>In (A) <i>AKY</i> and (B) <i>BBJ</i>, case samples with PSA 1–10 ng/ml and all the control sample...
<p><b>A)</b> and <b>B)</b> Levels of hyaluronan and N-ERC/mesothelin, respectively, in the validatio...
<p>Sensitivity and specificity was maximized at a sensitivity of 0.858 and specificity of 0.623.</p
<p>Fig 3a. ROC curves for different biomarkers and PSI. Fig 3b. ROC curves for the PSI & MR-proADM p...
<p>(a) shows genes contained in the integrated BRCA pathway, (c) shows genes contained in the GBM KE...
<p>Values along the indicated diagonal line (<i>line of no-discrimination</i>) reflect a random gues...
<p>ROC curves for cardiovascular morbidity and mortality of three models: traditional risk markers (...
<p>ROC curves for combined risk factors (RF) alone, TRAIL alone, and the model. TRAIL: AUC 0.59 (95%...
Model A (blue line) incorporates classical risk factors and five GWAS-identified SNPs, whereas model...
<p>In training set (A), at each immunohistochemical staining score of 38 tissue molecules and 3 sero...
<p>The sensitivity (y axis) was plotted versus 1−specificity (x axis) in case of each potential biom...
<p>ROC curves analyses to represent sensitivity/specificity of each biomarker, and the Area Under th...
<p>True positive rate is denoted TPR and false positive rate is denoted FPR in the Figure. A. Evalua...
<p>Performance of the random forest classifier (red) compared to a commercial mesothelin assay (blue...
<p>ROC curves and AUCs for the clinical (solid blue), ECG (dashed red), and combined (dotted black) ...
<p>In (A) <i>AKY</i> and (B) <i>BBJ</i>, case samples with PSA 1–10 ng/ml and all the control sample...